跳至主要内容
临床试验/CTRI/2020/06/025981
CTRI/2020/06/025981尚未招募4 期

Comparison of high strength topical levofloxacin (1.5%) monotherapy with standard combination therapy for the management of bacterial keratitis: A Randomized controlled trial.â??

Santen India Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Microbiologically proven bacterial keratitis
  • 2. Size of ulcer ranging between 2-8mm
  • 3. Patients willing to participate and follow up

排除标准

  • a) Patients with age less than 18 years
  • b) Mixed infections; concomitant fungal, viral or acanthamoeba infections
  • c) Size of ulcer less than 2mm and more than 8 mm
  • d) Impending perforation or presence of corneal perforation at the time of presentation
  • e) Associated endophthalmitis
  • f) Pregnant and lactating females
  • g) Patient not willing to participate and follow up
  • h) Patients with known allergy to fluoroquinolones, aminoglycosides and cephalosporins

研究者

发起方
Santen India Pvt Ltd

相似试验

nderstanding the role of 1.5% levofloxacin drops in... | 临床试验